RALA and sarcoma: Through the analysis of cox proportional hazard model, the results showed that the expression levels of RALA were correlated with OS in breast invasive cancer (BRCA) (p=0.0250), kidney chromophobe (KICH) (p=0.0419), kidney renal clear cell cancer (KIRC) (p=0.0022), HCC (p=0.0005), MESO (p=0.0004), PAAD (p=0.0046) and Sarcoma (SARC) (p=0.0111) (Figure 3A); with DSS in BRCA (p=0.0223), KIRC (p=0.0093), LGG (p=0.0437), HCC (p=0.0097), MESO (p=0.0129), PAAD (p=0.0221), SARC (p=0.0204) (Figure 3B).